518 related articles for article (PubMed ID: 24846507)
21. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
[TBL] [Abstract][Full Text] [Related]
22. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
23. Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.
Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park SW; Serruys PW; Park SJ
Catheter Cardiovasc Interv; 2017 Aug; 90(2):177-185. PubMed ID: 28112467
[TBL] [Abstract][Full Text] [Related]
24. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.
Zheng Z; Xu B; Zhang H; Guan C; Xian Y; Zhao Y; Fan H; Yang Y; Wang W; Gao R; Hu S
JACC Cardiovasc Interv; 2016 Jun; 9(11):1102-11. PubMed ID: 27282597
[TBL] [Abstract][Full Text] [Related]
25. Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Diabetic Patients With Multivessel and/or Left Main Coronary Artery Disease: A Meta-Analysis.
Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
Angiology; 2019 Sep; 70(8):765-773. PubMed ID: 30995117
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
[TBL] [Abstract][Full Text] [Related]
27. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.
Garg A; Rao SV; Agrawal S; Theodoropoulos K; Mennuni M; Sharma A; Garg L; Ferrante G; Meelu OA; Sargsyan D; Reimers B; Cohen M; Kostis JB; Stefanini GG
Am J Cardiol; 2017 Jun; 119(12):1942-1948. PubMed ID: 28433215
[TBL] [Abstract][Full Text] [Related]
28. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
[TBL] [Abstract][Full Text] [Related]
29. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials.
Bundhun PK; Wu ZJ; Chen MH
Cardiovasc Diabetol; 2016 Jan; 15():2. PubMed ID: 26739589
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials.
Nerlekar N; Ha FJ; Verma KP; Bennett MR; Cameron JD; Meredith IT; Brown AJ
Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27899408
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous coronary invervention versus coronary artery bypass grafting: a meta-analysis.
Smit Y; Vlayen J; Koppenaal H; Eefting F; Kappetein AP; Mariani MA
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):831-8.e1-13. PubMed ID: 25467373
[TBL] [Abstract][Full Text] [Related]
32. Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.
Raja SG; Benedetto U; Ilsley CD; Amrani M;
Int J Cardiol; 2015; 189():153-8. PubMed ID: 25897895
[TBL] [Abstract][Full Text] [Related]
33. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
[TBL] [Abstract][Full Text] [Related]
34. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
[TBL] [Abstract][Full Text] [Related]
35. Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study.
Jeong YJ; Ahn JM; Hyun J; Lee J; Kim JH; Yang Y; Choe K; Park H; Kang DY; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park SJ; Park DW
J Am Heart Assoc; 2021 Jul; 10(14):e019834. PubMed ID: 34238026
[TBL] [Abstract][Full Text] [Related]
36. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
Mahmoud AN; Elgendy IY; Mentias A; Saad M; Ibrahim W; Mojadidi MK; Nairooz R; Eshtehardi P; David Anderson R; Samady H
Catheter Cardiovasc Interv; 2017 Oct; 90(4):541-552. PubMed ID: 28296170
[TBL] [Abstract][Full Text] [Related]
38. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis.
De Rosa S; Polimeni A; Sabatino J; Indolfi C
BMC Cardiovasc Disord; 2017 Sep; 17(1):240. PubMed ID: 28877676
[TBL] [Abstract][Full Text] [Related]
40. Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
Ahmad Y; Howard JP; Arnold AD; Cook CM; Prasad M; Ali ZA; Parikh MA; Kosmidou I; Francis DP; Moses JW; Leon MB; Kirtane AJ; Stone GW; Karmpaliotis D
Eur Heart J; 2020 Sep; 41(34):3228-3235. PubMed ID: 32118272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
